Led development and execution of global commercial Pricing and Reimbursement strategy across the Gene Therapy and Rare Disease portfolios. Ensured equitable and consistent pricing activities across different customer groups and geographies.• Developed technology based International Pricing Platform utilizing Agile Methodology acting as the Agile Product Owner.• Designed and implemented innovative Gene Therapy pricing strategy and execution models, including US and European contracting opportunities.

Led the Global Market Access team for the $20B product portfolio, including, novel Antibiotics, Anti-Fungals, post patent Cardiovascular and Pain brands, Sterile Injectables, and launching Biosimilars. Developed and delivered differentiated product value propositions and targeted messaging by user segment through global face-to-face Physician Key Opinion Leader (KOL) and payer engagement forums• Key contributor to portfolio management evaluation team, enabling external investment and internal development decisions. • Led primary and secondary market research to develop and operationalize revenue generating and patient focused solutions.• Served as team lead for up to 16 global employees.

Cross-functional project manager leading strategic projects and daily office operations for 600+ product portfolio. Oversight of an entire commercial organization structural change (re-organization).• Developed a new operating matrix to enable new product launch and integration into daily operations across Development, Regulatory, Commercial Operations, Manufacturing, and Distribution.• Developed innovative solutions to address limited manufacturing capacity during Sterile Injectable supply shortage.

Team leader responsible for launching, defending and expanding Physician demand and Patient utilization of Pfizer’s portfolio across all Latin American markets. Generated Customer insights through primary market research and face to face engagements. • Key contributor to Neuroscience commercial development team.• Led regional - local cross functional collaboration in Brazil and Mexico to revitalize of the go to market approach for Inflammation and Oncology treatments, resulting in therapeutic area leadership.

Director, Global Health & Value, 2013-2014Enabled growth of Cardiovascular franchise across emerging markets through collaboration with local affiliates.• Launched Eliquis in over 22 emerging markets and enabled growth of post patent cardiovascular franchise.• Led development and implementation of multi-product portfolio promotional program across emerging markets.

Optimized enterprise-wide financial returns through effective global opportunity and risk management.• Developed Excel based forecast model to quantify global revenue risks and opportunities resulting from environmental and commercial triggers. • Managed all aspects of Pfizer’s global pricing approval system, including international reference pricing, parallel trade and associated analytics.

Member of inaugural team to develop commercial contracting and cross portfolio customer engagement capabilities. Developed and implemented transformational promotional program, resulting in year one incremental sales of $10M.

Developed and executed contracting strategies for U.S. Hospitals, Specialty Pharmacies, Oncology GPOs, Long Term Care (LTC) Pharmacies, and Group Purchasing Organizations (GPOs). Revamped LTC contracting strategy in light of the Medicare Modernization Act (MMA).

Developed contract offerings for Pharmacy Benefit Manager (PBM) customers, including those undergoing a merger thereby managing a contract totaling over $1B in annual sales.

Developed new methodology for collecting patient data for all CV franchise products. Assisted development of Diovan’s sales aid.

Designed and implemented research studies investigating topics in Managed Care, profitability of pharmaceutical marketing campaigns, and public relations promotional materials for Fortune 500 clients.

Performed new product concept testing for pharmaceutical and equity research clients